Presentation THT 2025 Special Late-Breaking Clinical Science Abstract: Mechanical Circulatory Support for High-Risk PCI With a Novel VITALYST System: Early Feasibility and Safety Results of the VITALYST Study Presenter: Kevin Croce February 11, 2025
Presentation THT 2025 Evidence Is Getting STRONGer That Rapid GDMT Uptitration After an AHF Event Is Effective Regardless of LVEF Presenter: Gad Cotter February 11, 2025
Presentation THT 2025 Renal Dysfunction as a Primary Mechanism of Symptoms in (Most) Patients With HFpEF Presenter: Jeffrey Testani February 11, 2025
Presentation THT 2025 Comprehensive Mapping of Exercise Hemodynamic Responses and Multi-Organ System Reserve Capacity in HFpEF and Implications for Individualized Management Presenter: Isabela Landsteiner February 11, 2025
Presentation THT 2025 Assessing the Impact of Hospital Volume Thresholds on In-Hospital Mortality Among Heart Transplant Patients: An Analysis of the National Inpatient Sample (2017-2021) Presenter: Viet Nghi Tran February 11, 2025
Presentation THT 2025 Increasing Reach: Using TeleHealth to Get STRONGer Presenter: Daniel Bensimhon February 11, 2025
Presentation THT 2025 Mechanisms by Which Cardiometablic Drugs Help People Feel Better Presenter: Barry Borlaug February 11, 2025
Presentation THT 2025 Increasing Access: Reducing Referral Delay in Ambulatory Advanced HF Patients Presenter: Nir Uriel February 11, 2025
Presentation Controversies and Advances 2025 Changing ABO Blood Type During Ex Vivo Perfusion Presenter: Fardad Esmailian January 31, 2025
Presentation Miami Valves 2025 Percutaneous Stenting of Severe LVAD Outflow Graft Obstruction Presenter: Nicholas J. Ruggiero II January 30, 2025
Presentation Miami Valves 2025 Left Atrium to Coronary Sinus Shunting: Edwards’ APTURE shunt and ALT-FLOW II trial status Presenter: Santiago Garcia January 30, 2025
Presentation Miami Valves 2025 Recurrent Heart Failure after M-TEER More than the Mitral Valve Presenter: Christian F. Witzke January 30, 2025
Presentation AHA 2024 Randomized Study Comparing PK/PD Properties of a Novel Intranasal Formulation of Bumetanide to Oral and IV Formulations Presenter: Daniel Bensimhon November 18, 2024
Presentation AHA 2024 Routine spironolactone in Acute Myocardial Infarction, results from the CLEAR SYNERGY OASIS 9 trial Presenter: Sanjit S Jolly November 17, 2024
Presentation AHA 2024 Novel AI to Assess Intracardiac Filling Pressure: The Non-invasive SEISMocardiogram In Cardiovascular Monitoring for Heart Failure I (SEISMIC-HF I) Study Presenter: Liviu Klein November 16, 2024
Presentation AHA 2024 Effect of Tirzepatide on Major Heart Failure Outcomes in Patients With Heart Failure With a Preserved Ejection Fraction and Obesity: The SUMMIT Trial Presenter: Milton Packer November 16, 2024
Presentation TCT 2024 How AI Applications Can Change the Landscape of Heart Failure Management Presenter: Timothy Poterucha October 30, 2024
Presentation TCT 2024 Managing a Difficult Triad: RHF, RV Dysfunction, and Severe TR Presenter: Alexander Lauten October 30, 2024
Presentation TCT 2024 The House is ON FIRE! Acute Decompensated Heart Failure in Severe AS Presenter: Mark Bieniarz October 30, 2024
Presentation TCT 2024 TCT 793: Unraveling the Connection: Central Obesity, Atherosclerosis, and Heart Failure in African Americans: Focusing on the Mediating Role of Atherosclerosis Presenter: Chun-Wei Lee October 29, 2024